| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.01 | 0.8 |